| Role |
Name |
Disclosure |
Details |
| Author | Charles E Rawlings III, MD, Consulting Surgeon, Department of Neurosurgery, Rawlings Neurosurgical Consulting | Nothing to disclose | Details | | Medical Editor | Paul L Penar, MD, Professor, Department of Surgery, Division of Neurosurgery, University of Vermont School of Medicine | Nothing to disclose | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Allen R Wyler, MD, Former Medical Director, Northstar Neuroscience, Inc | Nothing to disclose | Details | | CME Editor | Herbert H Engelhard III, MD, PhD, Director, UIC Neuro-Oncology Program, Chief, Division of Neuro-Oncology, Associate Professor, Department of Neurosurgery, University of Illinois at Chicago | Nothing to disclose | Details | | Chief Editor | Allen R Wyler, MD, Former Medical Director, Northstar Neuroscience, Inc | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Charles E Rawlings III, Author |
The contributor discloses no conflict of interest. |
|